Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Appeals court does not block US mandate to cover cancer screenings, HIV drugs

Published 06/21/2024, 03:58 PM
Updated 06/21/2024, 06:40 PM
© Reuters. File photo: Sample laboratory equipment is displayed at the University of Pennsylvania, Perelman School of Medicine and Abramson Cancer Center in Philadelphia, Pennsylvania January 15, 2016.  REUTERS/Mark Makela/File photo

By Brendan Pierson

(Reuters) -A U.S. appeals court on Friday refused to block a federal mandate requiring health insurers to cover preventive care services like cancer screenings and HIV-preventing medication at no extra cost to patients, but ruled against the government on a key legal issue that leaves the mandate's future in doubt.

A unanimous panel of the 5th U.S. Circuit Court of Appeals agreed with a group of Christian businesses suing to challenge the mandate that claimed that the way services were chosen for coverage violates the U.S. Constitution.

However, the panel found that U.S. District Judge Reed O'Connor in Fort Worth, Texas had gone too far by blocking the mandate nationwide in March 2023, and instead blocked its enforcement only against the businesses that brought the lawsuit. O'Connor's ruling had been on hold while the appeals court considered the case.

Major U.S. medical groups have said that eliminating the preventive care mandate would put patients at risk and increase healthcare costs.

The panel also ordered O'Connor to reconsider his decision to uphold mandatory coverage of certain vaccines and childhood screening services, which the businesses had also challenged. The panel said O'Connor had not considered some relevant legal issues, though it did not weigh in on how he should decide.

While the 5th Circuit's ruling allows the government to continue enforcing the mandate, it could provide support for other employers or insurers wishing to challenge it.

The plaintiffs were represented by conservative group America First Legal. Gene Hamilton, the group's executive director, in a statement called Friday's decision "a victory for the Constitution, the rule of law, and every American who does not want unelected bureaucrats making decisions about their healthcare coverage."

The U.S. Department of Health and Human Services (HHS) did not immediately respond to a request for comment.

In their 2020 lawsuit, the businesses objected to covering pre-exposure prophylaxis (PrEP) for HIV on religious grounds, but also argued that the entire mandate violated the U.S. Constitution by having an HHS-appointed task force choose what treatments must be covered. A task force with that much power must be appointed by the president and confirmed by the Senate, they said.

Both O'Connor and the 5th Circuit agreed with that argument, and the 5th Circuit rejected the government's claim that HHS Secretary Xavier Becerra could fix the problem retroactively by "ratifying" the task force's decisions.

Two members of the panel, Circuit Judges Don Willett and Cory Wilson, were appointed by Republican former President Donald Trump. The third, Circuit Judge Irma Carrillo Ramirez, was appointed by President Joe Biden, a Democrat.

© Reuters. File photo: Sample laboratory equipment is displayed at the University of Pennsylvania, Perelman School of Medicine and Abramson Cancer Center in Philadelphia, Pennsylvania January 15, 2016.  REUTERS/Mark Makela/File photo

The preventive care mandate is part of the 2010 Affordable Care Act, often called Obamacare because it was championed by then-President Barack Obama. O'Connor drew widespread attention in 2019 by ruling that the entire act was unconstitutional, which was later overturned.

His ruling on the preventive care mandate did not apply to preventive services the task force recommended before the ACA was enacted, including breast cancer screening.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.